HomeCompareNEXI vs QYLD

NEXI vs QYLD: Dividend Comparison 2026

NEXI yields 666666.67% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEXI wins by $8.275235618773884e+34M in total portfolio value
10 years
NEXI
NEXI
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full NEXI calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — NEXI vs QYLD

📍 NEXI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEXIQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEXI + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEXI pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEXI
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, NEXI beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEXI + QYLD for your $10,000?

NEXI: 50%QYLD: 50%
100% QYLD50/50100% NEXI
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NEXI right now

NEXI
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Price Target
$3.33
+1109900.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-65.0
Piotroski
2/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEXI buys
0
QYLD buys
0
No recent congressional trades found for NEXI or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEXIQYLD
Forward yield666666.67%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.275235618773884e+34M$25.4K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$5,659.31
Total dividends collected$8.275075881065991e+34M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: NEXI vs QYLD ($10,000, DRIP)

YearNEXI PortfolioNEXI Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$66,677,367$66,666,666.67$10,352$1,192.36+$66.67MNEXI
2$415,506,651,117$415,435,306,334.37$10,830$1,347.57+$415506.64MNEXI
3$2,419,908,598,386,268$2,419,464,006,269,573.00$11,460$1,539.07+$2419908598.37MNEXI
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$12,275$1,777.84+$13171697643084.44MNEXI
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$13,323$2,078.95+$67004927492790120.00MNEXI
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$14,667$2,463.34+$318562277003514871808.00MNEXI
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$16,396$2,960.57+$1.415484168853553e+24MNEXI
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$18,631$3,612.97+$5.878130573362507e+27MNEXI
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$21,548$4,482.15+$2.2813793009840744e+31MNEXI
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$25,398$5,659.31+$8.275235618773884e+34MNEXI

NEXI vs QYLD: Complete Analysis 2026

NEXIStock

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Full NEXI Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this NEXI vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEXI vs SCHDNEXI vs JEPINEXI vs ONEXI vs KONEXI vs MAINNEXI vs XYLDNEXI vs JEPQNEXI vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.